Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Informe acción XSSC:603896

Capitalización de mercado: CN¥4.3b

Zhejiang Shouxiangu Pharmaceutical Crecimiento futuro

Future controles de criterios 2/6

Zhejiang Shouxiangu Pharmaceutical is forecast to grow earnings and revenue by 19.4% and 16.1% per annum respectively. EPS is expected to grow by 18.8% per annum. Return on equity is forecast to be 13% in 3 years.

Información clave

19.4%

Tasa de crecimiento de los beneficios

18.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Personal Products26.4%
Tasa de crecimiento de los ingresos16.1%
Rentabilidad financiera futura13.0%
Cobertura de analistas

Low

Última actualización25 Oct 2024

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Previsiones de crecimiento de beneficios e ingresos

XSSC:603896 - Estimaciones futuras de los analistas y datos financieros pasados (CNY Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20261,090384N/A4252
12/31/2025972335N/A3822
12/31/2024871289N/A3252
9/30/2024714234-306263N/A
6/30/2024765265-365283N/A
3/31/2024799269-256286N/A
12/31/2023784254-99315N/A
9/30/2023864287-31316N/A
6/30/2023851286173318N/A
3/31/2023832281172339N/A
12/31/2022829278159341N/A
9/30/2022795244140334N/A
6/30/2022799228139339N/A
3/31/2022797219123310N/A
12/31/2021767201135297N/A
9/30/2021722172153281N/A
6/30/2021717164204300N/A
3/31/2021677160192284N/A
12/31/2020636152191256N/A
9/30/2020597134172241N/A
6/30/2020529119147209N/A
3/31/202051411396179N/A
12/31/2019547124116208N/A
9/30/201953110596191N/A
6/30/201953910090180N/A
3/31/2019550115-20186N/A
12/31/2018511108-61172N/A
9/30/201846198-75153N/A
6/30/2018430102N/A147N/A
3/31/2018409100N/A131N/A
12/31/201737089N/A111N/A
9/30/201734289N/A113N/A
6/30/201733385N/A100N/A
3/31/201731784N/A101N/A
12/31/201631581N/A96N/A
12/31/201530263N/A85N/A
12/31/201430269N/A103N/A
12/31/201325354N/A66N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: 603896's forecast earnings growth (19.4% per year) is above the savings rate (2.9%).

Beneficios vs. Mercado: 603896's earnings (19.4% per year) are forecast to grow slower than the CN market (25.8% per year).

Beneficios de alto crecimiento: 603896's earnings are forecast to grow, but not significantly.

Ingresos vs. Mercado: 603896's revenue (16.1% per year) is forecast to grow faster than the CN market (14% per year).

Ingresos de alto crecimiento: 603896's revenue (16.1% per year) is forecast to grow slower than 20% per year.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: 603896's Return on Equity is forecast to be low in 3 years time (13%).

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y